Blacks and Hispanics have higher inpatient use for mycosis fungoidesApril 15, 2021Diversity in MedicineMedical Dermatology
Despite new ichthyosis treatment recommendations, ‘many questions still exist’April 12, 2021PediatricsMedical DermatologyRare Diseases
VEXAS: A novel rheumatologic, hematologic syndrome that’s making wavesApril 7, 2021Rare DiseasesMedical Dermatology
COVID-19’s impact on lupus inpatients examined in studyMarch 24, 2021COVID-19 UpdatesAutoimmune DiseasesMedical Dermatology
New analysis eyes the surgical landscape for hidradenitis suppurativaMarch 23, 2021Dermatologic SurgeryMedical DermatologyMixed Topics
Checkpoint inhibitor–induced rheumatic complications often arise lateMarch 15, 2021Psoriatic ArthritisMedical Dermatology
Nearly 20% of lupus patients have severe infection in first decade after diagnosisMarch 11, 2021Infectious DiseasesAutoimmune DiseasesMedical Dermatology
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquineMarch 2, 2021PediatricsAutoimmune DiseasesMedical Dermatology
Consider home subcutaneous immune globulin for refractory dermatomyositisFebruary 17, 2021Medical DermatologyAutoimmune Diseases
Cumulative exposure to high-potency topical steroid doses drives osteoporosis fracturesFebruary 16, 2021Atopic DermatitisPsoriasisMedical Dermatology
A 35-year-old male who takes antiseizure medications, has asymptomatic lesions on his nose and cheeks, present since birthFebruary 11, 2021Medical DermatologyRare Diseases
Expert calls for paradigm shift in lab monitoring of some dermatology drugsFebruary 11, 2021AcneInfectious DiseasesMedical DermatologyPsoriasis
Molecular insights suggest novel therapies for hidradenitis suppurativaFebruary 10, 2021Medical DermatologyWounds
Survey finds practice gaps in counseling women with hidradenitis suppurativa about pregnancyFebruary 5, 2021Medical Dermatology
Delusional infestation surges during COVID-19 pandemicFebruary 4, 2021Medical DermatologyMixed TopicsCOVID-19 Updates
